{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T05:46:10Z","timestamp":1785735970230,"version":"3.56.0"},"reference-count":236,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T00:00:00Z","timestamp":1785715200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell Dev. Biol."],"abstract":"<jats:p>\n                    Hepatocellular carcinoma and cholangiocarcinoma, the most common primary liver cancers, are usually considered quite different pathologies. However, convergent metabolic reprogramming across different progenitor cells can result in similar molecular alterations and, even in a combined form of cancer that is characterized by transitional features and a shared phenotype. In this review, we summarize essential steps in glucose and lipid metabolism to distinguish similarities in glucose and energy metabolism reprogramming from divergent lipid remodeling in different types of primary liver cancers. We show the convergent nature of metabolic alterations in glucose decomposition and related mitochondrial enzymes. Also, we outline the essential role of lactate in promoting cell viability, adaptation to increased biomass synthesis, and fueling surrounding cancer cells to support their growth and proliferation. Lipid metabolism, in contrast, was found to be dramatically different between primary liver cancers. Hepatocellular carcinoma relies on\n                    <jats:italic>de novo<\/jats:italic>\n                    fatty acids synthesis, for which mitochondrial activity shifts from energy production to citrate efflux. Cholangiocarcinoma, in contrast, relies on fatty acids uptake from the extracellular space and, at later stages, even engages in beta-oxidation, which is uncharacteristic of hepatocellular carcinoma. This yields an altered lipid portrait for these pathologies despite the overall convergent alterations in energy metabolism. With this review, we provide not only fundamental insights for further primary liver tumor metabolism investigation, but also an emphasis on the independence of lipid alterations from energy metabolism reprogramming, vital for further basic and translational applications of metabolomics and lipidomics to a broad range of cancers.\n                  <\/jats:p>","DOI":"10.3389\/fcell.2026.1890663","type":"journal-article","created":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T05:31:46Z","timestamp":1785735106000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Beyond the convergence of metabolic reprogramming in primary liver cancer: a comprehensive review on energy and lipids metabolism"],"prefix":"10.3389","volume":"14","author":[{"given":"Galina S.","family":"Stupnikova","sequence":"first","affiliation":[{"name":"Laboratory for Molecular Medical Diagnostics, Moscow Institute of Physics and Technology","place":["Dolgoprudny, Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor A.","family":"Popov","sequence":"additional","affiliation":[{"name":"Laboratory for Molecular Medical Diagnostics, Moscow Institute of Physics and Technology","place":["Dolgoprudny, Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanislav I.","family":"Pekov","sequence":"additional","affiliation":[{"name":"Laboratory for Molecular Medical Diagnostics, Moscow Institute of Physics and Technology","place":["Dolgoprudny, Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.freeradbiomed.2019.08.007","article-title":"Pyruvate kinase M2: a simple molecule with complex functions","volume":"143","author":"Alquraishi","year":"2019","journal-title":"Free Radic. Biol. Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"11780","DOI":"10.3748\/wjg.v20.i33.11780","article-title":"Characterization of monocarboxylate transporter activity in hepatocellular carcinoma","volume":"20","author":"Alves","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.2353\/ajpath.2009.080596","article-title":"GLUT1 expression is increased in hepatocellular carcinoma and promotes tumorigenesis","volume":"174","author":"Amann","year":"2009","journal-title":"Am. J. Pathol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.metabol.2014.04.003","article-title":"De novo lipogenesis in health and disease","volume":"63","author":"Ameer","year":"2014","journal-title":"Metabolism"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1053\/j.gastro.2011.12.005","article-title":"Genomic and genetic characterization of cholangiocarcinoma identifies therapeutic targets for tyrosine kinase inhibitors","volume":"142","author":"Andersen","year":"2012","journal-title":"Gastroenterology"},{"key":"B6","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.mam.2012.07.010","article-title":"SLC27 fatty acid transport proteins","volume":"34","author":"Anderson","year":"2013","journal-title":"Mol. Asp. Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.3390\/ijms24032409","article-title":"Primary liver cancers: connecting the dots of cellular studies and epidemiology with metabolomics","volume":"24","author":"Berkemeyer","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"B8","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1002\/hep.26350","article-title":"Tissue metabolomics of hepatocellular carcinoma: tumor energy metabolism and the role of transcriptomic classification","volume":"58","author":"Beyo\u011flu","year":"2013","journal-title":"Hepatology"},{"key":"B9","doi-asserted-by":"publisher","first-page":"751","DOI":"10.21037\/jgo.2019.03.10","article-title":"Frequency and prognostic significance of isocitrate dehydrogenase 1 mutations in cholangiocarcinoma: a systematic literature review","volume":"10","author":"Boscoe","year":"2019","journal-title":"J. Gastrointest. Oncol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"218066","DOI":"10.1016\/j.canlet.2025.218066","article-title":"STAT3 induced BRD9 activation promotes intrahepatic cholangiocarcinoma progression by enhancing CD36 controlled fatty acid metabolism","volume":"634","author":"Bu","year":"2025","journal-title":"Cancer Lett."},{"key":"B11","doi-asserted-by":"publisher","first-page":"158658","DOI":"10.1016\/j.bbalip.2020.158658","article-title":"Role of lipids in pathophysiology, diagnosis and therapy of hepatocellular carcinoma","volume":"1865","author":"Buechler","year":"2020","journal-title":"Biochim. Biophys. Acta - Mol. Cell Biol. Lipids"},{"key":"B12","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.jhep.2019.06.001","article-title":"Molecular and histological correlations in liver cancer","volume":"71","author":"Calderaro","year":"2019","journal-title":"J. Hepatol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"8290","DOI":"10.1038\/s41467-023-43749-3","article-title":"Deep learning-based phenotyping reclassifies combined hepatocellular-cholangiocarcinoma","volume":"14","author":"Calderaro","year":"2023","journal-title":"Nat. Commun."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1053\/j.gastro.2010.12.006","article-title":"Increased lipogenesis, induced by AKT-mTORC1-RPS6 signaling, promotes development of human hepatocellular carcinoma","volume":"140","author":"Calvisi","year":"2011","journal-title":"Gastroenterology"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.3892\/mmr.2019.10399","article-title":"Expression of GLS1 in intrahepatic cholangiocarcinoma and its clinical significance","volume":"20","author":"Cao","year":"2019","journal-title":"Mol. Med. Rep."},{"key":"B16","doi-asserted-by":"publisher","first-page":"2882","DOI":"10.21037\/tcr-20-1751","article-title":"Systemic characterization of the SLC family genes reveals SLC26A6 as a novel oncogene in hepatocellular carcinoma","volume":"10","author":"Cao","year":"2021","journal-title":"Transl. Cancer Res."},{"key":"B17","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1111\/liv.13998","article-title":"Classifications and misclassification in cholangiocarcinoma","volume":"39","author":"Cardinale","year":"2019","journal-title":"Liver Int."},{"key":"B18","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1093\/clinchem\/46.7.901","article-title":"Quantitative analysis of aldolase A mRNA in liver discriminates between hepatocellular carcinoma and cirrhosis","volume":"46","author":"Castaldo","year":"2000","journal-title":"Clin. Chem."},{"key":"B19","doi-asserted-by":"publisher","first-page":"2538","DOI":"10.18632\/oncotarget.2991","article-title":"Co-expression of PKM2 and TRIM35 predicts survival and recurrence in hepatocellular carcinoma","volume":"6","author":"Chen","year":"2015","journal-title":"Oncotarget"},{"key":"B20","doi-asserted-by":"publisher","first-page":"e1583","DOI":"10.1097\/MD.0000000000001583","article-title":"Low expression of LDHB correlates with unfavorable survival in hepatocellular carcinoma: strobe-compliant article","volume":"94","author":"Chen","year":"2015","journal-title":"Med. (Baltimore)"},{"key":"B21","doi-asserted-by":"publisher","first-page":"18805","DOI":"10.1002\/jcb.29196","article-title":"MicroRNA-450b-3p inhibits cell growth by targeting phosphoglycerate kinase 1 in hepatocellular carcinoma","volume":"120","author":"Chen","year":"2019","journal-title":"J. Cell Biochem."},{"key":"B22","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/nature13490","article-title":"Functional polarization of tumour-associated macrophages by tumour-derived lactic acid","volume":"513","author":"Colegio","year":"2014","journal-title":"Nature"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1275543","DOI":"10.3389\/fcell.2023.1275543\/full","article-title":"The crosstalk among the physical tumor microenvironment and the effects of glucose deprivation on tumors in the past decade","volume":"11","author":"Cui","year":"2023","journal-title":"Front. Cell Dev. Biol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s13402-019-00479-3","article-title":"CD147 augmented monocarboxylate transporter-1\/4 expression through modulation of the Akt-FoxO3-NF-\u03baB pathway promotes cholangiocarcinoma migration and invasion","volume":"43","author":"Dana","year":"2020","journal-title":"Cell Oncol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s00418-009-0590-4","article-title":"Distinct temporospatial expression patterns of glycolysis-related proteins in human hepatocellular carcinoma","volume":"132","author":"Daskalow","year":"2009","journal-title":"Histochem Cell Biol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.ejca.2017.11.024","article-title":"Circulating oncometabolite D-2-hydroxyglutarate enantiomer is a surrogate marker of isocitrate dehydrogenase\u2013mutated intrahepatic cholangiocarcinomas","volume":"90","author":"Delahousse","year":"2018","journal-title":"Eur. J. Cancer"},{"key":"B27","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/s41467-017-02733-4","article-title":"Hexokinase-2 depletion inhibits glycolysis and induces oxidative phosphorylation in hepatocellular carcinoma and sensitizes to metformin","volume":"9","author":"DeWaal","year":"2018","journal-title":"Nat. Commun."},{"key":"B28","doi-asserted-by":"publisher","first-page":"722","DOI":"10.2174\/0115680266290367240130054142","article-title":"Molecular biomarkers in cholangiocarcinoma: focus on bile","volume":"24","author":"Dolbnya","year":"2024","journal-title":"Curr. Top. Med. Chem."},{"key":"B29","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.biopha.2014.12.010","article-title":"Pyruvate kinase M2 affects liver cancer cell behavior through up-regulation of HIF-1\u03b1 and Bcl-xL in culture","volume":"69","author":"Dong","year":"2015","journal-title":"Biomed. Pharmacother."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.2174\/0115680096317314240723054739","article-title":"Neomorphic IDH heterodimer mutants: an underestimated point in cancer pathogenesis","volume":"25","author":"Dorovatovskaia","year":"2025","journal-title":"Curr. Cancer Drug Targets"},{"key":"B31","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1042\/bj2510677","article-title":"Analysis of the phosphofructokinase subunits and isoenzymes in human tissues","volume":"251","author":"Dunaway","year":"1988","journal-title":"Biochem. J."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1158\/0008-5472.CAN-12-2796","article-title":"Acidity generated by the tumor microenvironment drives local invasion","volume":"73","author":"Estrella","year":"2013","journal-title":"Cancer Res."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1016\/j.biopha.2016.10.108","article-title":"Nuclear PKM2 expression, an independent risk factor for ER after curative resection of hepatocellular carcinoma","volume":"84","author":"Fan","year":"2016","journal-title":"Biomed. Pharmacother."},{"key":"B34","doi-asserted-by":"publisher","first-page":"187","DOI":"10.22038\/ijbms.2017.8246","article-title":"The miR-383-LDHA axis regulates cell proliferation, invasion and glycolysis in hepatocellular cancer","volume":"20","author":"Fang","year":"2017","journal-title":"Iran. J. Basic Med. Sci."},{"key":"B35","doi-asserted-by":"publisher","first-page":"946","DOI":"10.3390\/life13040946","article-title":"Aiding cancer\u2019s \u201csweet tooth\u201d: role of hexokinases in metabolic reprogramming","volume":"13","author":"Farooq","year":"2023","journal-title":"Life"},{"key":"B36","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1159\/000539349","article-title":"Hepatocellular carcinoma: prevention, diagnosis, and treatment","volume":"33","author":"Feng","year":"2024","journal-title":"Med. Princ. Pract."},{"key":"B37","doi-asserted-by":"publisher","first-page":"6124","DOI":"10.1002\/cam4.1820","article-title":"Lactate dehydrogenase A: a key player in carcinogenesis and potential target in cancer therapy","volume":"7","author":"Feng","year":"2018","journal-title":"Cancer Med."},{"key":"B38","doi-asserted-by":"publisher","first-page":"3067","DOI":"10.1021\/acs.jproteome.9b00185","article-title":"Metabolomic analysis of liver tissues for characterization of hepatocellular carcinoma","volume":"18","author":"Ferrarini","year":"2019","journal-title":"J. Proteome Res."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1136\/gutjnl-2017-315193","article-title":"CPT2 downregulation adapts HCC to lipid-rich environment and promotes carcinogenesis via acylcarnitine accumulation in obesity","volume":"67","author":"Fujiwara","year":"2018","journal-title":"Gut"},{"key":"B40","doi-asserted-by":"publisher","first-page":"18859","DOI":"10.1038\/s41598-019-55211-w","article-title":"Mutant IDH1 confers resistance to energy stress in normal biliary cells through PFKP-induced aerobic glycolysis and AMPK activation","volume":"9","author":"Fujiwara","year":"2019","journal-title":"Sci. Rep."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1007\/s00432-014-1888-8","article-title":"Monocarboxylate transporter 4 predicts poor prognosis in hepatocellular carcinoma and is associated with cell proliferation and migration","volume":"141","author":"Gao","year":"2015","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"45913","DOI":"10.1038\/srep45913","article-title":"Quantitative proteomics by SWATH-MS reveals sophisticated metabolic reprogramming in hepatocellular carcinoma tissues","volume":"7","author":"Gao","year":"2017","journal-title":"Sci. Rep."},{"key":"B43","doi-asserted-by":"publisher","first-page":"691","DOI":"10.3892\/ol.2019.11191","article-title":"Prognostic value of glucose transporter 3 expression in hepatocellular carcinoma","volume":"19","author":"Gao","year":"2019","journal-title":"Oncol. Lett."},{"key":"B44","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1586\/14737140.4.3.449","article-title":"Recently elucidated energy catabolism pathways provide opportunities for novel treatments in hepatocellular carcinoma","volume":"4","author":"Geschwind","year":"2004","journal-title":"Expert Rev. Anticancer Ther."},{"key":"B45","doi-asserted-by":"publisher","first-page":"3117","DOI":"10.1111\/liv.14604","article-title":"Rapid automated diagnosis of primary hepatic tumour by mass spectrometry and artificial intelligence","volume":"40","author":"Giordano","year":"2020","journal-title":"Liver Int."},{"key":"B46","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1002\/hep.510230413","article-title":"Comparison of glyceraldehyde-3-phosphate dehydrogenase and 28S-ribosomal RNA gene expression in human hepatocellular carcinoma","volume":"23","author":"Gong","year":"1996","journal-title":"Hepatology"},{"key":"B47","doi-asserted-by":"publisher","first-page":"28618","DOI":"10.1074\/jbc.M204047200","article-title":"In vivo functional characterization of the aldolase B gene enhancer","volume":"277","author":"Gregori","year":"2002","journal-title":"J. Biol. Chem."},{"key":"B48","doi-asserted-by":"publisher","first-page":"12317","DOI":"10.1073\/pnas.95.21.12317","article-title":"Normal hepatic glucose production in the absence of GLUT2 reveals an alternative pathway for glucose release from hepatocytes","volume":"95","author":"Guillam","year":"1998","journal-title":"Proc. Natl. Acad. Sci."},{"key":"B49","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.1021\/acs.jproteome.2c00472","article-title":"Quantitative proteomics reveals down-regulated glycolysis\/gluconeogenesis in the large-duct type intrahepatic cholangiocarcinoma","volume":"21","author":"Guo","year":"2022","journal-title":"J. Proteome Res."},{"key":"B50","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1007\/s10620-014-3364-3","article-title":"Evidence for heightened hexokinase II immunoexpression in hepatocyte dysplasia and hepatocellular carcinoma","volume":"60","author":"Guzman","year":"2015","journal-title":"Dig. Dis. Sci."},{"key":"B51","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.jhep.2004.11.020","article-title":"Hypoxia stimulates proliferation of human hepatoma cells through the induction of hexokinase II expression","volume":"42","author":"Gwak","year":"2005","journal-title":"J. Hepatol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"135","DOI":"10.2147\/hp.s99044","article-title":"Phosphorylation of the PDH complex precedes HIF-1-mediated effects and PDK1 upregulation during the first hours of hypoxic treatment in HCC cells","volume":"4","author":"Haan","year":"2016","journal-title":"Hypoxia"},{"key":"B53","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.1111\/jgh.15976","article-title":"Probe electrospray ionization mass spectrometry-based rapid diagnosis of liver tumors","volume":"37","author":"Hakoda","year":"2022","journal-title":"J. Gastroenterol. Hepatol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1038\/s41416-020-0814-x","article-title":"IDH mutation in glioma: molecular mechanisms and potential therapeutic targets","volume":"122","author":"Han","year":"2020","journal-title":"Br. J. Cancer"},{"key":"B55","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.hbpd.2020.05.010","article-title":"ATP-citrate lyase regulates stemness and metastasis in hepatocellular carcinoma via the Wnt\/\u03b2-catenin signaling pathway","volume":"20","author":"Han","year":"2021","journal-title":"Hepatobiliary Pancreat. Dis. Int."},{"key":"B56","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"B57","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/nrc.2016.77","article-title":"Reprogramming glucose metabolism in cancer: can it be exploited for cancer therapy?","volume":"16","author":"Hay","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"B58","doi-asserted-by":"publisher","first-page":"e3000803","DOI":"10.1371\/journal.pbio.3000803","article-title":"Loss of hepatic aldolase B activates Akt and promotes hepatocellular carcinogenesis by destabilizing the Aldob\/Akt\/PP2A protein complex","volume":"18","author":"He","year":"2020","journal-title":"PLoS Biol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"36","DOI":"10.17998\/jlc.2026.03.02.163","article-title":"Systemic therapy for combined hepatocellular-cholangiocarcinoma: a comprehensive review of chemotherapy, immunotherapy, and targeted therapy","volume":"26","author":"Hong","year":"2026","journal-title":"J. Liver Cancer"},{"key":"B60","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.devcel.2016.02.012","article-title":"Amino acids rather than glucose account for the majority of cell mass in proliferating Mammalian cells","volume":"36","author":"Hosios","year":"2016","journal-title":"Dev. Cell"},{"key":"B61","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1038\/nrendo.2015.122","article-title":"Metabolic functions of FABPs\u2014mechanisms and therapeutic implications","volume":"11","author":"Hotamisligil","year":"2015","journal-title":"Nat. Rev. Endocrinol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2174\/1871520615666150716110942","article-title":"The prognostic value of serum LDH levels in patients with hepatocellualr carcinoma after hepatic resection","volume":"15","author":"Hu","year":"2015","journal-title":"Anticancer Agents Med. Chem."},{"key":"B63","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1002\/hep.28887","article-title":"Acetylation of PGK1 promotes liver cancer cell proliferation and tumorigenesis","volume":"65","author":"Hu","year":"2017","journal-title":"Hepatology"},{"key":"B64","doi-asserted-by":"publisher","first-page":"116966","DOI":"10.1016\/j.lfs.2019.116966","article-title":"Metformin attenuates hepatoma cell proliferation by decreasing glycolytic flux through the HIF-1\u03b1\/PFKFB3\/PFK1 pathway","volume":"239","author":"Hu","year":"2019","journal-title":"Life Sci."},{"key":"B65","doi-asserted-by":"publisher","first-page":"4992","DOI":"10.1158\/0008-5472.CAN-13-0308","article-title":"Metabolic characterization of hepatocellular carcinoma using nontargeted tissue metabolomics","volume":"73","author":"Huang","year":"2013","journal-title":"Cancer Res."},{"key":"B66","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.jhep.2014.04.035","article-title":"CD147 promotes reprogramming of glucose metabolism and cell proliferation in HCC cells by inhibiting the p53-dependent signaling pathway","volume":"61","author":"Huang","year":"2014","journal-title":"J. Hepatol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1023\/a:1020501021222","article-title":"Human mitochondrial transmembrane metabolite carriers: tissue distribution and its implication for mitochondrial disorders","volume":"30","author":"Huizing","year":"1998","journal-title":"J. Bioenerg. Biomembr."},{"key":"B68","doi-asserted-by":"publisher","first-page":"7882","DOI":"10.1038\/ncomms8882","article-title":"PARP14 promotes the Warburg effect in hepatocellular carcinoma by inhibiting JNK1-dependent PKM2 phosphorylation and activation","volume":"6","author":"Iansante","year":"2015","journal-title":"Nat. Commun."},{"key":"B69","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s12967-018-1475-x","article-title":"Preoperative metabolic tumor volume of intrahepatic cholangiocarcinoma measured by 18F-FDG-PET is associated with the KRAS mutation status and prognosis","volume":"16","author":"Ikeno","year":"2018","journal-title":"J. Transl. Med."},{"key":"B70","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/s0076-6879(82)90121-5","article-title":"Pyruvate kinase isozymes from rat","volume":"90","author":"Imamura","year":"1982","journal-title":"Methods Enzymol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.semcdb.2015.08.004","article-title":"Pyruvate kinase: function, regulation and role in cancer","volume":"43","author":"Israelsen","year":"2015","journal-title":"Semin. Cell Dev. Biol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"1186064","DOI":"10.3389\/fphar.2023.1186064\/full","article-title":"Identification of a lipid metabolism-related gene for cancer immunotherapy","volume":"14","author":"Jiang","year":"2023","journal-title":"Front. Pharmacol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1038\/s12276-023-00971-9","article-title":"Targeting glutamine metabolism as a therapeutic strategy for cancer","volume":"55","author":"Jin","year":"2023","journal-title":"Exp. Mol. Med."},{"key":"B74","first-page":"4399","article-title":"Kinetic characteristics of citrate influx and efflux with mitochondria from Morris hepatomas 3924A and 16","volume":"42","author":"Kaplan","year":"1982","journal-title":"Cancer Res."},{"key":"B75","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s12072-014-9536-6","article-title":"Upregulation of CD147 protects hepatocellular carcinoma cell from apoptosis through glycolytic switch via HIF-1 and MCT-4 under hypoxia","volume":"8","author":"Ke","year":"2014","journal-title":"Hepatol. Int."},{"key":"B76","doi-asserted-by":"publisher","first-page":"801","DOI":"10.3390\/cancers16040801","article-title":"Cholangiocarcinoma: recent advances in molecular pathobiology and therapeutic approaches","volume":"16","author":"Khosla","year":"2024","journal-title":"Cancers"},{"key":"B77","doi-asserted-by":"publisher","first-page":"68381","DOI":"10.18632\/oncotarget.20266","article-title":"SLC2A2 (GLUT2) as a novel prognostic factor for hepatocellular carcinoma","volume":"8","author":"Kim","year":"2017","journal-title":"Oncotarget"},{"key":"B78","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1016\/j.humpath.2011.12.007","article-title":"Isocitrate dehydrogenase 1 and 2 mutations in cholangiocarcinoma","volume":"43","author":"Kipp","year":"2012","journal-title":"Hum. Pathol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1038\/s41416-023-02256-4","article-title":"Convergent genomic diversity and novel BCAA metabolism in intrahepatic cholangiocarcinoma","volume":"128","author":"Kitagawa","year":"2023","journal-title":"Br. J. Cancer"},{"key":"B80","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/1723184","article-title":"Prognostic value of lactate dehydrogenase in patients with hepatocellular carcinoma: a meta-analysis","volume":"2018","author":"Kong","year":"2018","journal-title":"Biomed. Res. Int."},{"key":"B81","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nrc3038","article-title":"Otto Warburg\u2019s contributions to current concepts of cancer metabolism","volume":"11","author":"Koppenol","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"B82","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3389\/fonc.2017.00087","article-title":"Emerging role of the pentose phosphate pathway in hepatocellular carcinoma","volume":"7","author":"Kowalik","year":"2017","journal-title":"Front. Oncol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1016\/j.bbalip.2016.08.014","article-title":"Ceramide and polyunsaturated phospholipids are strongly reduced in human hepatocellular carcinoma","volume":"1861","author":"Krautbauer","year":"2016","journal-title":"Biochim. Biophys. Acta - Mol. Cell Biol. Lipids"},{"key":"B84","doi-asserted-by":"publisher","first-page":"18229","DOI":"10.18632\/oncotarget.7571","article-title":"Liver fatty acid-binding protein (L-FABP) promotes cellular angiogenesis and migration in hepatocellular carcinoma","volume":"7","author":"Ku","year":"2016","journal-title":"Oncotarget"},{"key":"B85","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1016\/j.humpath.2014.03.008","article-title":"Different expression of glucose transporters in the progression of intrahepatic cholangiocarcinoma","volume":"45","author":"Kubo","year":"2014","journal-title":"Hum. Pathol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"G1168","DOI":"10.1152\/ajpgi.1997.272.5.G1168","article-title":"Kinetic and molecular identification of sodium-dependent glucose transporter in normal rat cholangiocytes","volume":"272","author":"Lazaridis","year":"1997","journal-title":"Am. J. Physiol-Gastrointest Liver Physiol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1021\/bi00829a016","article-title":"Distribution of fructose diphosphate aldolase variants in biological systems","volume":"8","author":"Lebherz","year":"1969","journal-title":"Biochemistry"},{"key":"B88","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1038\/s41467-017-00906-9","article-title":"Stabilization of phosphofructokinase 1 platelet isoform by AKT promotes tumorigenesis","volume":"8","author":"Lee","year":"2017","journal-title":"Nat. Commun."},{"key":"B89","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1002\/hep.28508","article-title":"Differential requirement for de novo lipogenesis in cholangiocarcinoma and hepatocellular carcinoma of mice and humans","volume":"63","author":"Li","year":"2016","journal-title":"Hepatology"},{"key":"B90","doi-asserted-by":"publisher","first-page":"2550","DOI":"10.3390\/ijms18122550","article-title":"Aberrant lipid metabolism in hepatocellular carcinoma revealed by liver lipidomics","volume":"18","author":"Li","year":"","journal-title":"Int. J. Mol. Sci."},{"key":"B91","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1038\/bjc.2017.323","article-title":"Genistein suppresses aerobic glycolysis and induces hepatocellular carcinoma cell death","volume":"117","author":"Li","year":"","journal-title":"Br. J. Cancer"},{"key":"B92","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.1002\/ijc.31022","article-title":"By inhibiting PFKFB3, aspirin overcomes sorafenib resistance in hepatocellular carcinoma","volume":"141","author":"Li","year":"","journal-title":"Int. J. Cancer"},{"key":"B93","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1038\/s41419-018-0494-0","article-title":"PGC1\u03b1 promotes cholangiocarcinoma metastasis by upregulating PDHA1 and MPC1 expression to reverse the Warburg effect","volume":"9","author":"Li","year":"2018","journal-title":"Cell Death Dis."},{"key":"B94","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1038\/s43018-020-0086-7","article-title":"Aldolase B suppresses hepatocellular carcinogenesis by inhibiting G6PD and pentose phosphate pathways","volume":"1","author":"Li","year":"2020","journal-title":"Nat. Cancer"},{"key":"B95","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.7150\/ijbs.59068","article-title":"Aldolase A enhances intrahepatic cholangiocarcinoma proliferation and invasion through promoting glycolysis","volume":"17","author":"Li","year":"2021","journal-title":"Int. J. Biol. Sci."},{"key":"B96","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1186\/s12885-024-12970-8","article-title":"Clinicopathological characteristics and prognosis of combined hepatocellular cholangiocarcinoma","volume":"24","author":"Li","year":"","journal-title":"BMC Cancer"},{"key":"B97","doi-asserted-by":"publisher","first-page":"130","DOI":"10.5306\/wjco.v15.i1.130","article-title":"Fatty acid binding protein 5 is a novel therapeutic target for hepatocellular carcinoma","volume":"15","author":"Li","year":"","journal-title":"World J. Clin. Oncol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.tibs.2015.12.001","article-title":"The warburg effect: how does it benefit cancer cells?","volume":"41","author":"Liberti","year":"2016","journal-title":"Trends Biochem. Sci."},{"key":"B99","doi-asserted-by":"publisher","first-page":"8579658","DOI":"10.1155\/2021\/8579658","article-title":"Mechanistic investigation on the regulation of FABP1 by the IL-6\/miR-603 signaling in the pathogenesis of hepatocellular carcinoma","volume":"2021","author":"Lin","year":"2021","journal-title":"Biomed. Res. Int."},{"key":"B100","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13045-024-01527-8","article-title":"Metabolic reprogramming in the tumor microenvironment of liver cancer","volume":"17","author":"Lin","year":"2024","journal-title":"J. Hematol. Oncol."},{"key":"B101","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1002\/hep.27085","article-title":"Conjugated bile acids promote cholangiocarcinoma cell invasive growth through activation of sphingosine 1-phosphate receptor 2","volume":"60","author":"Liu","year":"2014","journal-title":"Hepatol"},{"key":"B102","doi-asserted-by":"publisher","first-page":"e86872","DOI":"10.1371\/journal.pone.0086872","article-title":"miR-122 targets pyruvate kinase M2 and affects metabolism of hepatocellular carcinoma","volume":"9","author":"Liu","year":"2014","journal-title":"PLoS One"},{"key":"B103","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1002\/hep.29202","article-title":"Glyceraldehyde-3-phosphate dehydrogenase promotes liver tumorigenesis by modulating phosphoglycerate dehydrogenase","volume":"66","author":"Liu","year":"2017","journal-title":"Hepatology"},{"key":"B104","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2021\/5680968","article-title":"High expression levels of SLC38A1 are correlated with poor prognosis and defective immune infiltration in hepatocellular carcinoma","volume":"2021","author":"Liu","year":"2021","journal-title":"J. Oncol."},{"key":"B105","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1186\/s12885-023-10903-5","article-title":"ACSL4 serves as a novel prognostic biomarker correlated with immune infiltration in cholangiocarcinoma","volume":"23","author":"Liu","year":"2023","journal-title":"BMC Cancer"},{"key":"B106","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","article-title":"Hepatocellular carcinoma","volume":"7","author":"Llovet","year":"2021","journal-title":"Nat. Rev. Dis. Primer"},{"key":"B107","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.jtbi.2008.05.033","article-title":"Role of the malate\u2013aspartate shuttle on the metabolic response to myocardial ischemia","volume":"254","author":"Lu","year":"2008","journal-title":"J. Theor. Biol."},{"key":"B108","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1146\/annurev-cellbio-092910-154237","article-title":"Aerobic glycolysis: meeting the metabolic requirements of cell proliferation","volume":"27","author":"Lunt","year":"2011","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"B109","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/s41419-021-03596-w","article-title":"The fatty acid receptor CD36 promotes HCC progression through activating Src\/PI3K\/AKT axis-dependent aerobic glycolysis","volume":"12","author":"Luo","year":"2021","journal-title":"Cell Death Dis."},{"key":"B110","doi-asserted-by":"publisher","first-page":"3679","DOI":"10.1158\/0008-5472.can-20-3944","article-title":"Suppression of ACADM-mediated fatty acid oxidation promotes hepatocellular carcinoma via aberrant CAV1\/SREBP1 signaling","volume":"81","author":"Ma","year":"2021","journal-title":"Cancer Res."},{"key":"B111","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1186\/s12935-023-03027-0","article-title":"Spatially resolved visualization of reprogrammed metabolism in hepatocellular carcinoma by mass spectrometry imaging","volume":"23","author":"Ma","year":"2023","journal-title":"Cancer Cell Int."},{"key":"B112","doi-asserted-by":"publisher","first-page":"101491","DOI":"10.1016\/j.gendis.2024.101491","article-title":"Emerging roles for fatty acid oxidation in cancer","volume":"12","author":"Ma","year":"2025","journal-title":"Genes Dis."},{"key":"B113","doi-asserted-by":"publisher","first-page":"679","DOI":"10.21037\/jgo-24-685","article-title":"Downregulation of CPT2 promotes proliferation and migration through the TNF\u03b1\/NF-\u03baB pathway in cholangiocarcinoma","volume":"16","author":"Mao","year":"2025","journal-title":"J. Gastrointest. Oncol."},{"key":"B114","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.3390\/biomedicines9111664","article-title":"Mitochondria-mediated apoptosis of HCC cells triggered by knockdown of glutamate dehydrogenase 1: perspective for its inhibition through Quercetin and permethylated anigopreissin A","volume":"9","author":"Marsico","year":"2021","journal-title":"Biomedicines"},{"key":"B115","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1042\/BJ20141171","article-title":"Mitochondrial pyruvate transport: a historical perspective and future research directions","volume":"466","author":"McCommis","year":"2015","journal-title":"Biochem. J."},{"key":"B116","doi-asserted-by":"publisher","first-page":"141","DOI":"10.3390\/biom11020141","article-title":"The mitochondrial citrate carrier SLC25A1\/CIC and the fundamental role of citrate in cancer, inflammation and beyond","volume":"11","author":"Mosaoa","year":"2021","journal-title":"Biomolecules"},{"key":"B117","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.mam.2012.07.001","article-title":"The SLC2 (GLUT) family of membrane transporters","volume":"34","author":"Mueckler","year":"2013","journal-title":"Mol. Asp. Med."},{"key":"B118","doi-asserted-by":"publisher","first-page":"4722","DOI":"10.1158\/0008-5472.CAN-12-3797","article-title":"Proteomic and lipidomic signatures of lipid metabolism in NASH-associated hepatocellular carcinoma","volume":"73","author":"Muir","year":"2013","journal-title":"Cancer Res."},{"key":"B119","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1016\/j.celrep.2014.04.037","article-title":"Oxidation of alpha-Ketoglutarate is required for reductive carboxylation in cancer cells with mitochondrial defects","volume":"7","author":"Mullen","year":"2014","journal-title":"Cell Rep."},{"key":"B120","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1007\/s00795-019-00230-9","article-title":"Expression of fatty-acid-binding protein 5 in intrahepatic and extrahepatic cholangiocarcinoma: the possibility of different energy metabolisms in anatomical location","volume":"53","author":"Nakagawa","year":"2020","journal-title":"Med. Mol. Morphol."},{"key":"B121","doi-asserted-by":"publisher","first-page":"BSR20200219","DOI":"10.1042\/BSR20200219","article-title":"Immunohistochemical staining reveals differential expression of ACSL3 and ACSL4 in hepatocellular carcinoma and hepatic gastrointestinal metastases","volume":"40","author":"Ndiaye","year":"2020","journal-title":"Biosci. Rep."},{"key":"B122","doi-asserted-by":"publisher","first-page":"e17598","DOI":"10.1016\/j.heliyon.2023.e17598","article-title":"A pan-cancer analysis of SLC1A5 in human cancers","volume":"9","author":"Ni","year":"2023","journal-title":"Heliyon"},{"key":"B123","doi-asserted-by":"crossref","first-page":"13807","DOI":"10.1016\/S0021-9258(18)67091-7","article-title":"The M1- and M2-type isozymes of rat pyruvate kinase are produced from the same gene by alternative RNA splicing","volume":"261","author":"Noguchi","year":"1986","journal-title":"J. Biol. Chem."},{"key":"B124","doi-asserted-by":"crossref","first-page":"14366","DOI":"10.1016\/S0021-9258(18)47947-1","article-title":"The L- and R-type isozymes of rat pyruvate kinase are produced from a single gene by use of different promoters","volume":"262","author":"Noguchi","year":"1987","journal-title":"J. Biol. Chem."},{"key":"B125","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.jcmgh.2017.05.004","article-title":"Identification of the consistently altered metabolic targets in human hepatocellular carcinoma","volume":"4","author":"Nwosu","year":"2017","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"key":"B126","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.3892\/or.2017.6172","article-title":"Mitochondrial pyruvate carrier modulates the epithelial-mesenchymal transition in cholangiocarcinoma","volume":"39","author":"Ohashi","year":"2018","journal-title":"Oncol. Rep."},{"key":"B127","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1111\/liv.12466","article-title":"Aberrant expression of monocarboxylate transporter 4 in tumour cells predicts an unfavourable outcome in patients with hepatocellular carcinoma","volume":"34","author":"Ohno","year":"2014","journal-title":"Liver Int."},{"key":"B128","doi-asserted-by":"publisher","first-page":"1073274817744621","DOI":"10.1177\/1073274817744621","article-title":"Liver resection and surgical strategies for management of primary liver cancer","volume":"25","author":"Orcutt","year":"2018","journal-title":"Cancer Control"},{"key":"B129","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1620\/tjem.214.213","article-title":"Fatty acid binding protein: localization and functional significance in the brain","volume":"214","author":"Owada","year":"2008","journal-title":"Tohoku J. Exp. Med."},{"key":"B130","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.jhep.2022.05.037","article-title":"Zucman-Rossi J. Pathogenesis of primary liver carcinomas","volume":"78","author":"Paradis","year":"2023","journal-title":"J. Hepatol."},{"key":"B131","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.3390\/cells9102308","article-title":"Cancer metabolism: phenotype, signaling and therapeutic targets","volume":"9","author":"Park","year":"2020","journal-title":"Cells"},{"key":"B132","doi-asserted-by":"publisher","first-page":"16615","DOI":"10.1074\/jbc.r114.563148","article-title":"The pyruvate dehydrogenase complexes: structure-based function and regulation","volume":"289","author":"Patel","year":"2014","journal-title":"J. Biol. Chem."},{"key":"B133","first-page":"1047","article-title":"Clinical implication of glucose transport and metabolism evaluated by 18F-FDG PET in hepatocellular carcinoma","volume":"33","author":"Paudyal","year":"","journal-title":"Int. J. Oncol."},{"key":"B134","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1111\/j.1349-7006.2007.00683.x","article-title":"Expression of glucose transporters and hexokinase II in cholangiocellular carcinoma compared using [18 F]-2-fluro-2-deoxy- d -glucose positron emission tomography","volume":"99","author":"Paudyal","year":"","journal-title":"Cancer Sci."},{"key":"B135","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cmet.2015.12.006","article-title":"The emerging hallmarks of cancer metabolism","volume":"23","author":"Pavlova","year":"2016","journal-title":"Cell Metab."},{"key":"B136","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.molmet.2019.07.006","article-title":"Monocarboxylate transporters in cancer","volume":"33","author":"Payen","year":"2020","journal-title":"Mol. Metab."},{"key":"B137","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1002\/mas.21883","article-title":"Mass spectrometry for neurosurgery: intraoperative support in decision-making","volume":"44","author":"Pekov","year":"2025","journal-title":"Mass Spectrom. Rev."},{"key":"B138","first-page":"1045","article-title":"Aberrant expression of the glycolytic enzymes aldolase B and type II hexokinase in hepatocellular carcinoma are predictive markers for advanced stage, early recurrence and poor prognosis","volume":"19","author":"Peng","year":"2008","journal-title":"Oncol. Rep."},{"key":"B139","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1146\/annurev-nutr-071812-161220","article-title":"Structure-function of CD36 and importance of fatty acid signal transduction in fat metabolism","volume":"34","author":"Pepino","year":"2014","journal-title":"Annu. Rev. Nutr."},{"key":"B140","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/s41571-021-00521-0","article-title":"The implications of IDH mutations for cancer development and therapy","volume":"18","author":"Pirozzi","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"B141","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/3683026","article-title":"Combination of Mitochondrial and Plasma Membrane Citrate Transporter Inhibitors Inhibits de novo Lipogenesis Pathway and Triggers Apoptosis in Hepatocellular Carcinoma Cells","volume":"2018","author":"Poolsri","year":"2018","journal-title":"Biomed. Res. Int."},{"key":"B142","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.clinre.2019.06.008","article-title":"PKM2 upregulation promotes malignancy and indicates poor prognosis for intrahepatic cholangiocarcinoma","volume":"44","author":"Qian","year":"2020","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"B143","doi-asserted-by":"publisher","first-page":"4397","DOI":"10.7150\/jca.43459","article-title":"Loss of PDK4 expression promotes proliferation, tumorigenicity, motility and invasion of hepatocellular carcinoma cells","volume":"11","author":"Qin","year":"2020","journal-title":"J. Cancer"},{"key":"B144","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1093\/jnci\/djq187","article-title":"Isocitrate dehydrogenase 1 and 2 mutations in cancer: alterations at a crossroads of cellular metabolism","volume":"102","author":"Reitman","year":"2010","journal-title":"J. Natl. Cancer Inst."},{"key":"B145","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1002\/hep.32344","article-title":"Cholangiocarcinoma progression depends on the uptake and metabolization of extracellular lipids","volume":"76","author":"Ruiz de Gauna","year":"2022","journal-title":"Hepatol. Baltim Md"},{"key":"B146","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.ejca.2021.11.023","article-title":"Global, regional and national burden of primary liver cancer by subtype","volume":"161","author":"Rumgay","year":"2022","journal-title":"Eur. J. Cancer"},{"key":"B147","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1002\/ijc.29564","article-title":"The pyruvate dehydrogenase complex in cancer: an old metabolic gatekeeper regulated by new pathways and pharmacological agents","volume":"138","author":"Saunier","year":"2016","journal-title":"Int. J. Cancer"},{"key":"B148","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/j.bbabio.2016.03.006","article-title":"Glutamine transport. From energy supply to sensing and beyond","volume":"1857","author":"Scalise","year":"2016","journal-title":"Biochim. Biophys. Acta BBA - Bioenerg."},{"key":"B149","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1194\/jlr.R067629","article-title":"Short- and medium-chain fatty acids in energy metabolism: the cellular perspective","volume":"57","author":"Sch\u00f6nfeld","year":"2016","journal-title":"J. Lipid Res."},{"key":"B150","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.2147\/jhc.s383922","article-title":"Expert insights on current treatments for hepatocellular carcinoma: clinical and molecular approaches and bottlenecks to progress","volume":"9","author":"Shannon","year":"2022","journal-title":"J. Hepatocell. Carcinoma"},{"key":"B151","doi-asserted-by":"publisher","first-page":"3898","DOI":"10.1111\/j.1742-4658.2012.08748.x","article-title":"Knockdown of lactate dehydrogenase A suppresses tumor growth and metastasis of human hepatocellular carcinoma","volume":"279","author":"Sheng","year":"2012","journal-title":"FEBS J."},{"key":"B152","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1038\/s41419-018-0435-y","article-title":"PFKFB3 blockade inhibits hepatocellular carcinoma growth by impairing DNA repair through AKT","volume":"9","author":"Shi","year":"2018","journal-title":"Cell Death Dis."},{"key":"B153","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1038\/s41417-020-00253-w","article-title":"microRNA-9-5p regulates the mitochondrial function of hepatocellular carcinoma cells through suppressing PDK4","volume":"28","author":"Si","year":"2021","journal-title":"Cancer Gene Ther."},{"key":"B154","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/1479-7364-5-3-170","article-title":"The human fatty acid-binding protein family: evolutionary divergences and functions","volume":"5","author":"Smathers","year":"2011","journal-title":"Hum. Genomics"},{"key":"B155","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1038\/s42255-024-01201-w","article-title":"Targeting aldolase A in hepatocellular carcinoma leads to imbalanced glycolysis and energy stress due to uncontrolled FBP accumulation","volume":"7","author":"Snaebjornsson","year":"2025","journal-title":"Nat. Metab."},{"key":"B156","doi-asserted-by":"publisher","first-page":"2302425","DOI":"10.1002\/advs.202302425","article-title":"Aldolase A accelerates cancer progression by modulating mRNA translation and protein biosynthesis via noncanonical mechanisms","volume":"10","author":"Song","year":"2023","journal-title":"Adv. Sci."},{"key":"B157","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1016\/S0021-9258(18)96733-5","article-title":"Substrate and product inhibition of rabbit muscle lactic dehydrogenase heart (H4) and muscle (M4) isozymes","volume":"241","author":"Stambaugh","year":"1966","journal-title":"J. Biol. Chem."},{"key":"B158","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1111\/brv.12140","article-title":"The return of metabolism: biochemistry and physiology of the pentose phosphate pathway","volume":"90","author":"Stincone","year":"2015","journal-title":"Biol. Rev."},{"key":"B159","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1134\/s1990750823600449","article-title":"Bile acid profiling for differential diagnosis of hepatobiliary cancers and cholelitiasis","volume":"19","author":"Stupnikova","year":"2025","journal-title":"Biochem. Mosc Suppl. Ser. B Biomed. Chem."},{"key":"B160","first-page":"2106","article-title":"Expression and prognostic value of glutamate dehydrogenase in extrahepatic cholangiocarcinoma patients","volume":"9","author":"Su","year":"2017","journal-title":"Am. J. Transl. Res."},{"key":"B161","doi-asserted-by":"publisher","first-page":"69","DOI":"10.2147\/jhc.s398632","article-title":"Evaluation of lactate dehydrogenase and alkaline phosphatase as predictive biomarkers in the prognosis of hepatocellular carcinoma and development of a new nomogram","volume":"10","author":"Su","year":"2023","journal-title":"J. Hepatocell. Carcinoma"},{"key":"B162","first-page":"101","article-title":"Mitochondrial and plasma membrane citrate transporters: discovery of selective inhibitors and application to structure\/function analysis","volume":"2","author":"Sun","year":"2010","journal-title":"Mol. Cell Pharmacol."},{"key":"B163","doi-asserted-by":"publisher","first-page":"e0168907","DOI":"10.1371\/journal.pone.0168907","article-title":"GLUT1 and ASCT2 as predictors for prognosis of hepatocellular carcinoma","volume":"11","author":"Sun","year":"2016","journal-title":"PLoS One"},{"key":"B164","doi-asserted-by":"publisher","first-page":"407","DOI":"10.3727\/096504018X15180451872087","article-title":"Overexpression of pyruvate dehydrogenase E1\u03b1 subunit inhibits warburg effect and induces cell apoptosis through mitochondria-mediated pathway in hepatocellular carcinoma","volume":"27","author":"Sun","year":"2019","journal-title":"Oncol. Res. Featur Preclin. Clin. Cancer Ther."},{"key":"B165","doi-asserted-by":"publisher","first-page":"1477267","DOI":"10.3389\/fimmu.2024.1477267","article-title":"The pathological significance and potential mechanism of ACLY in cholangiocarcinoma","volume":"15","author":"Sun","year":"2024","journal-title":"Front. Immunol."},{"key":"B166","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"B167","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1016\/j.gendis.2021.09.002","article-title":"Targeting fructose metabolism by glucose transporter 5 regulation in human cholangiocarcinoma","volume":"9","author":"Suwannakul","year":"2022","journal-title":"Genes Dis."},{"key":"B168","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.dld.2015.03.017","article-title":"Relationship between 18-F-fluoro-deoxy-d-glucose uptake and expression of glucose transporter 1 and pyruvate kinase M2 in intrahepatic cholangiocarcinoma","volume":"47","author":"Suzuki","year":"2015","journal-title":"Dig. Liver Dis."},{"key":"B169","doi-asserted-by":"publisher","first-page":"174","DOI":"10.21037\/jgo-20-534","article-title":"High expression of aldolase A is associated with tumor progression and poor prognosis in hepatocellular carcinoma","volume":"12","author":"Tang","year":"2021","journal-title":"J. Gastrointest. Oncol."},{"key":"B170","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3390\/metabo7040049","article-title":"Specificities of human hepatocellular carcinoma developed on non-alcoholic fatty liver disease in absence of cirrhosis revealed by tissue extracts 1H-NMR spectroscopy","volume":"7","author":"Teilhet","year":"2017","journal-title":"Metabolites"},{"key":"B171","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.bbrc.2017.01.139","article-title":"Targeting hexokinase II as a possible therapy for cholangiocarcinoma","volume":"484","author":"Thamrongwaranggoon","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B172","doi-asserted-by":"publisher","first-page":"267","DOI":"10.21873\/invivo.12255","article-title":"Aberrant GLUT1 expression is associated with carcinogenesis and progression of liver fluke-associated cholangiocarcinoma","volume":"35","author":"Thamrongwaranggoon","year":"2021","journal-title":"Vivo"},{"key":"B173","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1111\/cas.15699","article-title":"Lactic acidosis induces metabolic and phenotypic reprogramming in cholangiocarcinoma cells via the upregulation of thrombospondin-1","volume":"114","author":"Thamrongwaranggoon","year":"2023","journal-title":"Cancer Sci."},{"key":"B174","doi-asserted-by":"publisher","first-page":"503","DOI":"10.14670\/HH-11-819","article-title":"Overexpression of lactate dehydrogenase A in cholangiocarcinoma is correlated with poor prognosis","volume":"32","author":"Thonsri","year":"2017","journal-title":"Histol. Histopathol."},{"key":"B175","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s00125-014-3451-1","article-title":"GLUT2, glucose sensing and glucose homeostasis","volume":"58","author":"Thorens","year":"2015","journal-title":"Diabetologia"},{"key":"B176","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1159\/000438593","article-title":"Isocitrate dehydrogenase 2 suppresses the invasion of hepatocellular carcinoma cells via matrix metalloproteinase 9","volume":"37","author":"Tian","year":"2015","journal-title":"Cell Physiol. Biochem."},{"key":"B177","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41389-020-0207-2","article-title":"Dysregulation of the miR-148a\u2013GLUT1 axis promotes the progression and chemoresistance of human intrahepatic cholangiocarcinoma","volume":"9","author":"Tiemin","year":"2020","journal-title":"Oncogenesis"},{"key":"B178","doi-asserted-by":"publisher","first-page":"696961","DOI":"10.3389\/fphar.2021.696961\/full","article-title":"Targeting fatty acid synthase modulates metabolic pathways and inhibits cholangiocarcinoma cell progression","volume":"12","author":"Tomacha","year":"2021","journal-title":"Front. Pharmacol."},{"key":"B179","doi-asserted-by":"crossref","first-page":"4110","DOI":"10.1016\/S0021-9258(18)99819-4","article-title":"Effect of pH on the kinetics of frog muscle phosphofructokinase","volume":"241","author":"Trivedi","year":"1966","journal-title":"J. Biol. Chem."},{"key":"B180","doi-asserted-by":"publisher","first-page":"3081","DOI":"10.1038\/s41598-018-21361-6","article-title":"Decreased succinate dehydrogenase B in human hepatocellular carcinoma accelerates tumor malignancy by inducing the Warburg effect","volume":"8","author":"Tseng","year":"2018","journal-title":"Sci. Rep."},{"key":"B181","doi-asserted-by":"publisher","first-page":"e4","DOI":"10.1017\/erm.2019.4","article-title":"Warburg and Krebs and related effects in cancer","volume":"21","author":"Unterlass","year":"2019","journal-title":"Expert Rev. Mol. Med."},{"key":"B182","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1126\/science.123.3191.309","article-title":"On the origin of cancer cells","volume":"123","author":"Warburg","year":"1956","journal-title":"Science"},{"key":"B183","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/s1499-3872(15)60353-8","article-title":"Preoperative serum liver enzyme markers for predicting early recurrence after curative resection of hepatocellular carcinoma","volume":"14","author":"Wang","year":"2015","journal-title":"Hepatobiliary Pancreat. Dis. Int."},{"key":"B184","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.1194\/jlr.R056705","article-title":"Recent insights into the biological functions of liver fatty acid binding protein 1","volume":"56","author":"Wang","year":"2015","journal-title":"J. Lipid Res."},{"key":"B185","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1002\/hep.28415","article-title":"Acetyl\u2010coenzyme A carboxylase alpha promotion of glucose-mediated fatty acid synthesis enhances survival of hepatocellular carcinoma in mice and patients","volume":"63","author":"Wang","year":"2016","journal-title":"Hepatology"},{"key":"B186","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.freeradbiomed.2020.11.035","article-title":"The PGC1\u03b1\/NRF1-MPC1 axis suppresses tumor progression and enhances the sensitivity to sorafenib\/doxorubicin treatment in hepatocellular carcinoma","volume":"163","author":"Wang","year":"2021","journal-title":"Free Radic. Biol. Med."},{"key":"B187","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41389-021-00364-5","article-title":"Fatty acid transport protein-5 (FATP5) deficiency enhances hepatocellular carcinoma progression and metastasis by reprogramming cellular energy metabolism and regulating the AMPK-mTOR signaling pathway","volume":"10","author":"Wang","year":"2021","journal-title":"Oncogenesis"},{"key":"B188","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1002\/elps.202300007","article-title":"Lipidomic study and diagnosis of hepatocellular carcinoma tumor with rapid evaporative ionization mass spectrometry","volume":"44","author":"Wang","year":"2023","journal-title":"Electrophoresis"},{"key":"B189","doi-asserted-by":"publisher","first-page":"1416295","DOI":"10.3389\/fphar.2024.1416295","article-title":"Novel genetic alterations in liver cancer distinguish distinct clinical outcomes and combination immunotherapy responses","volume":"15","author":"Wang","year":"2024","journal-title":"Front. Pharmacol."},{"key":"B190","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1126\/science.124.3215.269","article-title":"On respiratory impairment in cancer cells","volume":"124","author":"Warburg","year":"1956","journal-title":"Science"},{"key":"B191","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1007\/BF01712130","article-title":"Versuche an \u00dcberlebendem carcinom-Gewebe","volume":"2","author":"Warburg","year":"1923","journal-title":"Klin. Wochenschr"},{"key":"B192","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.surg.2003.11.015","article-title":"Prognostic significance of Bcl-xL in human hepatocellular carcinoma","volume":"135","author":"Watanabe","year":"2004","journal-title":"Surgery"},{"key":"B193","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.jhep.2024.06.004","article-title":"Rare primary liver cancers: an EASL position paper","volume":"81","author":"Wege","year":"2024","journal-title":"J. Hepatol."},{"key":"B194","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1007\/978-3-662-46875-3_7225","article-title":"Metabolic reprogramming","volume-title":"Encyclopedia of Cancer","author":"White","year":"2015"},{"key":"B195","doi-asserted-by":"publisher","first-page":"19611","DOI":"10.1073\/pnas.1117773108","article-title":"Hypoxia promotes isocitrate dehydrogenase-dependent carboxylation of \u03b1-ketoglutarate to citrate to support cell growth and viability","volume":"108","author":"Wise","year":"2011","journal-title":"Proc. Natl. Acad. Sci."},{"key":"B196","doi-asserted-by":"publisher","first-page":"e115036","DOI":"10.1371\/journal.pone.0115036","article-title":"Switching of pyruvate kinase isoform L to M2 promotes metabolic reprogramming in hepatocarcinogenesis","volume":"9","author":"Wong","year":"2014","journal-title":"PLoS ONE"},{"key":"B197","doi-asserted-by":"publisher","first-page":"40621","DOI":"10.18632\/oncotarget.9746","article-title":"Lactic acidosis switches cancer cells from aerobic glycolysis back to dominant oxidative phosphorylation","volume":"7","author":"Wu","year":"2016","journal-title":"Oncotarget"},{"key":"B198","doi-asserted-by":"publisher","first-page":"101569","DOI":"10.1016\/j.isci.2020.101569","article-title":"Lipid droplets maintain energy homeostasis and glioblastoma growth via autophagic release of stored fatty acids","volume":"23","author":"Wu","year":"2020","journal-title":"iScience"},{"key":"B199","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.yexcr.2019.04.005","article-title":"GLS1 promotes proliferation in hepatocellular carcinoma cells via AKT\/GSK3\u03b2\/CyclinD1 pathway","volume":"381","author":"Xi","year":"2019","journal-title":"Exp. Cell Res."},{"key":"B200","doi-asserted-by":"publisher","first-page":"2250","DOI":"10.1093\/carcin\/bgs249","article-title":"The TNF-\u03b1\/ROS\/HIF-1-induced upregulation of FoxMI expression promotes HCC proliferation and resistance to apoptosis","volume":"33","author":"Xia","year":"2012","journal-title":"Carcinogenesis"},{"key":"B201","doi-asserted-by":"publisher","first-page":"953668","DOI":"10.3389\/fonc.2022.953668","article-title":"Glucometabolic reprogramming: from trigger to therapeutic target in hepatocellular carcinoma","volume":"12","author":"Xia","year":"2022","journal-title":"Front. Oncol."},{"key":"B202","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.3390\/ijms18081630","article-title":"PGK1 drives hepatocellular carcinoma metastasis by enhancing metabolic process","volume":"18","author":"Xie","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"B203","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1186\/s12943-017-0748-y","article-title":"HSP90 promotes cell glycolysis, proliferation and inhibits apoptosis by regulating PKM2 abundance via Thr-328 phosphorylation in hepatocellular carcinoma","volume":"16","author":"Xu","year":"2017","journal-title":"Mol. Cancer"},{"key":"B204","doi-asserted-by":"publisher","first-page":"2596","DOI":"10.1159\/000492702","article-title":"miR-122-5p inhibits the proliferation, invasion and growth of bile duct carcinoma cells by targeting ALDOA","volume":"48","author":"Xu","year":"2018","journal-title":"Cell Physiol. Biochem."},{"key":"B205","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.neo.2019.03.002","article-title":"The SIRT2\/cMYC pathway inhibits peroxidation-related apoptosis in cholangiocarcinoma through metabolic reprogramming","volume":"21","author":"Xu","year":"","journal-title":"Neoplasia"},{"key":"B206","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.1002\/cam4.2089","article-title":"SIRT3 elicited an anti-warburg effect through HIF1\u03b1\/PDK1\/PDHA1 to inhibit cholangiocarcinoma tumorigenesis","volume":"8","author":"Xu","year":"","journal-title":"Cancer Med."},{"key":"B207","doi-asserted-by":"publisher","first-page":"733","DOI":"10.3892\/ijo.2020.5098","article-title":"Inhibition of pyruvate dehydrogenase kinase-1 by dicoumarol enhances the sensitivity of hepatocellular carcinoma cells to oxaliplatin via metabolic reprogramming","volume":"57","author":"Xu","year":"2020","journal-title":"Int. J. Oncol."},{"key":"B208","doi-asserted-by":"publisher","first-page":"1697056","DOI":"10.3389\/fimmu.2025.1697056","article-title":"Metabolic collusion driving immune evasion in cholangiocarcinoma: unmasking the dual control of the immuno-metabolic microenvironment","volume":"16","author":"Xue","year":"2025","journal-title":"Front. Immunol."},{"key":"B209","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1016\/j.ejca.2004.12.037","article-title":"Co-ordinate activation of lipogenic enzymes in hepatocellular carcinoma","volume":"41","author":"Yahagi","year":"2005","journal-title":"Eur. J. Cancer"},{"key":"B210","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.cmet.2016.10.011","article-title":"Targeting stromal glutamine synthetase in tumors disrupts tumor microenvironment-regulated cancer cell growth","volume":"24","author":"Yang","year":"2016","journal-title":"Cell Metab."},{"key":"B211","doi-asserted-by":"publisher","first-page":"918","DOI":"10.7150\/jca.27226","article-title":"Downregulation of PDK4 increases lipogenesis and associates with poor prognosis in hepatocellular carcinoma","volume":"10","author":"Yang","year":"2019","journal-title":"J. Cancer"},{"key":"B212","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1016\/j.ajpath.2024.07.002","article-title":"Acyl-CoA synthetase medium-chain family member 5\u2013Mediated fatty acid metabolism dysregulation promotes the progression of hepatocellular carcinoma","volume":"194","author":"Yang","year":"2024","journal-title":"Am. J. Pathol."},{"key":"B213","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3892\/ol.2024.14242","article-title":"PGK1 is a potential biomarker for early diagnosis and prognosis of hepatocellular carcinoma","volume":"27","author":"Yi","year":"2024","journal-title":"Oncol. Lett."},{"key":"B214","doi-asserted-by":"publisher","first-page":"e2856","DOI":"10.1038\/cddis.2016.457","article-title":"Histone deacetylase 3 overexpression in human cholangiocarcinoma and promotion of cell growth via apoptosis inhibition","volume":"8","author":"Yin","year":"2017","journal-title":"Cell Death Dis."},{"key":"B215","doi-asserted-by":"publisher","first-page":"e178","DOI":"10.1097\/RLU.0000000000000640","article-title":"Analysis of the roles of glucose transporter 1 and hexokinase 2 in the metabolism of glucose by extrahepatic bile duct cancer cells","volume":"40","author":"Yoon","year":"2015","journal-title":"Clin. Nucl. Med."},{"key":"B216","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s12672-023-00830-z","article-title":"A comprehensive analysis of SLC25A1 expression and its oncogenic role in pan-cancer","volume":"14","author":"You","year":"2023","journal-title":"Discov. Oncol."},{"key":"B217","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.jss.2010.03.049","article-title":"Overexpression of ATA1\/SLC38A1 predicts future recurrence and death in Chinese patients with hilar cholangiocarcinoma","volume":"171","author":"Yu","year":"2011","journal-title":"J. Surg. Res."},{"key":"B218","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/1477-7819-12-78","article-title":"Overexpression of lactate dehydrogenase-A in human intrahepatic cholangiocarcinoma: its implication for treatment","volume":"12","author":"Yu","year":"2014","journal-title":"World J. Surg. Oncol."},{"key":"B219","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1186\/s12943-015-0462-6","article-title":"PKM2 regulates neural invasion of and predicts poor prognosis for human hilar cholangiocarcinoma","volume":"14","author":"Yu","year":"2015","journal-title":"Mol. Cancer"},{"key":"B220","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.trsl.2020.05.010","article-title":"Transcription factor HIF1\u03b1 promotes proliferation, migration, and invasion of cholangiocarcinoma via long noncoding RNA H19\/microRNA-612\/Bcl-2 axis","volume":"224","author":"Yu","year":"2020","journal-title":"Transl. Res."},{"key":"B221","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1007\/s12032-014-0278-z","article-title":"Genetic variations in IDH gene as prognosis predictors in TACE-treated hepatocellular carcinoma patients","volume":"31","author":"Zhang","year":"2014","journal-title":"Med. Oncol."},{"key":"B222","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.tranon.2015.11.006","article-title":"Lactate dehydrogenase is an important prognostic indicator for hepatocellular carcinoma after partial hepatectomy","volume":"8","author":"Zhang","year":"2015","journal-title":"Transl. Oncol."},{"key":"B223","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.bbrc.2016.05.007","article-title":"High expression of hexokinase domain containing 1 is associated with poor prognosis and aggressive phenotype in hepatocarcinoma","volume":"474","author":"Zhang","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B224","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.15252\/embj.201696151","article-title":"Cancer cell metabolism: the essential role of the nonessential amino acid, glutamine","volume":"36","author":"Zhang","year":"2017","journal-title":"EMBO J."},{"key":"B225","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12964-019-0332-8","article-title":"Low levels of pyruvate induced by a positive feedback loop protects cholangiocarcinoma cells from apoptosis","volume":"17","author":"Zhang","year":"2019","journal-title":"Cell Commun. Signal"},{"key":"B226","doi-asserted-by":"publisher","first-page":"4510","DOI":"10.1364\/boe.432654","article-title":"Explainable liver tumor delineation in surgical specimens using hyperspectral imaging and deep learning","volume":"12","author":"Zhang","year":"2021","journal-title":"Biomed. Opt. Express"},{"key":"B227","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1097\/hep.0000000000000784","article-title":"Oleic acid-PPAR\u03b3-FABP4 loop fuels cholangiocarcinoma colonization in lymph node metastases microenvironment","volume":"80","author":"Zhang","year":"2024","journal-title":"Hepatology"},{"key":"B228","doi-asserted-by":"publisher","first-page":"goae031","DOI":"10.1093\/gastro\/goae031","article-title":"Current advances and future directions in combined hepatocellular and cholangiocarcinoma","volume":"12","author":"Zhang","year":"2024","journal-title":"Gastroenterol. Rep."},{"key":"B229","doi-asserted-by":"publisher","first-page":"3500","DOI":"10.3748\/wjg.v24.i31.3500","article-title":"Immunometabolism: a novel perspective of liver cancer microenvironment and its influence on tumor progression","volume":"24","author":"Zhang","year":"2018","journal-title":"World J. Gastroenterol."},{"key":"B230","doi-asserted-by":"publisher","first-page":"1787784","DOI":"10.3389\/fcell.2026.1787784","article-title":"From organelles to therapy: rethinking combined hepatocellular-cholangiocarcinoma","volume":"14","author":"Zhang","year":"2026","journal-title":"Front. Cell Dev. Biol."},{"key":"B231","doi-asserted-by":"publisher","first-page":"108487","DOI":"10.1016\/j.celrep.2020.108487","article-title":"HCAR1\/MCT1 regulates tumor ferroptosis through the lactate-mediated AMPK-SCD1 activity and its therapeutic implications","volume":"33","author":"Zhao","year":"2020","journal-title":"Cell Rep."},{"key":"B232","doi-asserted-by":"publisher","first-page":"608641","DOI":"10.3389\/fonc.2021.608641","article-title":"Correlation between prognostic biomarker SLC1A5 and immune infiltrates in various types of cancers including hepatocellular carcinoma","volume":"11","author":"Zhao","year":"2021","journal-title":"Front. Oncol."},{"key":"B233","first-page":"2304","article-title":"Glucose 6 phosphatase dehydrogenase (G6PD): a novel diagnosis marker related to gastrointestinal cancers","volume":"15","author":"Zheng","year":"2023","journal-title":"Am. J. Transl. Res."},{"key":"B234","doi-asserted-by":"publisher","first-page":"3207","DOI":"10.1016\/j.celrep.2018.08.066","article-title":"CARM1 methylates GAPDH to regulate glucose metabolism and is suppressed in liver cancer","volume":"24","author":"Zhong","year":"2018","journal-title":"Cell Rep. 2018 Sept."},{"key":"B235","doi-asserted-by":"publisher","first-page":"102458","DOI":"10.1016\/j.redox.2022.102458","article-title":"GTPBP4 promotes hepatocellular carcinoma progression and metastasis via the PKM2 dependent glucose metabolism","volume":"56","author":"Zhou","year":"2022","journal-title":"Redox Biol."},{"key":"B236","doi-asserted-by":"publisher","first-page":"1697675","DOI":"10.3389\/fimmu.2025.1697675","article-title":"Immune cell metabolic reprogramming in hepatocellular carcinoma: mechanisms, tumor microenvironment, and future immunotherapeutic directions","volume":"16","author":"Zhou","year":"2026","journal-title":"Front. Immunol."}],"container-title":["Frontiers in Cell and Developmental Biology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2026.1890663\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T05:31:50Z","timestamp":1785735110000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2026.1890663\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,3]]},"references-count":236,"alternative-id":["10.3389\/fcell.2026.1890663"],"URL":"https:\/\/doi.org\/10.3389\/fcell.2026.1890663","relation":{},"ISSN":["2296-634X"],"issn-type":[{"value":"2296-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,3]]},"article-number":"1890663"}}